Ventilators

Introduction

Mechanical ventilator: device providing respiratory support when patient cannot breathe adequately. Setting: ICU, operating room, emergency transport, home care. Population: ~800,000 patients ventilated annually in US. Duration: hours (post-surgery) to months/years (chronic respiratory failure). COVID-19 impact: highlighted ventilator importance and global shortages. Engineering: precise control of pressure, volume, flow, and timing.

"The ventilator keeps patients alive when their lungs cannot. But it is also a double-edged sword—improper settings can damage the very lungs we are trying to save. The art is knowing how much support to give." -- Intensivist

Respiratory Physiology Review

Normal Breathing

Inspiration: diaphragm contracts (lowers), intercostals expand ribcage → negative pleural pressure → air flows in. Expiration: passive recoil (elastic lung tissue). Tidal volume: 500 mL (normal breath). Rate: 12-20 breaths/min. Minute ventilation: rate × tidal volume = 6-10 L/min.

Gas Exchange

Alveolar surface area: ~70 m² (tennis court). O2: diffuses from alveoli to blood (driven by partial pressure gradient). CO2: diffuses from blood to alveoli (20x faster than O2). Normal values: PaO2 80-100 mmHg, PaCO2 35-45 mmHg, pH 7.35-7.45. Failure: PaO2 < 60 or PaCO2 > 50 (respiratory failure).

Lung Mechanics

Compliance: volume change per pressure change (mL/cmH2O). Normal: 50-100 mL/cmH2O. Low compliance: stiff lungs (ARDS, fibrosis) → higher pressures needed. High compliance: floppy lungs (emphysema) → air trapping. Resistance: opposition to airflow (airway caliber). Normal: 2-5 cmH2O/L/s.

Equation of Motion

Paw = (V / C) + (R × Flow) + PEEPPaw = airway pressure (cmH2O)V = tidal volume (mL)C = compliance (mL/cmH2O)R = resistance (cmH2O/L/s)Flow = inspiratory flow (L/s)PEEP = positive end-expiratory pressure

Indications for Ventilation

Hypoxemic Respiratory Failure

PaO2 < 60 mmHg despite supplemental oxygen. Causes: pneumonia, ARDS, pulmonary edema, pulmonary embolism. Goal: maintain oxygenation (PaO2 > 60, SpO2 > 90%). Mechanism: positive pressure opens collapsed alveoli, improves V/Q matching.

Hypercapnic Respiratory Failure

PaCO2 > 50 mmHg with acidosis (pH < 7.30). Causes: COPD exacerbation, neuromuscular disease, drug overdose. Goal: reduce CO2, normalize pH. Mechanism: ventilator provides adequate minute ventilation.

Airway Protection

Unconscious patients: risk of aspiration (GCS ≤ 8). Post-surgical: airway management during recovery. Intubation: endotracheal tube secures airway. Duration: as brief as possible (extubate when safe).

Surgical Support

General anesthesia: paralyzed muscles cannot breathe. Duration: hours (procedure length). Weaning: extubate in recovery room (typically rapid). Special: one-lung ventilation (thoracic surgery).

Ventilator Components

Gas Delivery System

Gas source: compressed air + oxygen (hospital piped or cylinders). Blender: mixes air and O2 to set FiO2 (21-100%). Flow generator: turbine or bellows creates positive pressure. Valves: inspiratory and expiratory (control flow direction). Humidifier: heated humidifier or HME (heat-moisture exchanger).

Patient Circuit

Inspiratory limb: delivers gas from ventilator to patient. Expiratory limb: returns exhaled gas to ventilator. Y-piece: connects both limbs to endotracheal tube. Filters: bacterial/viral filters on expiratory limb. Compliance: circuit stretches under pressure (compensated by ventilator).

Sensors

Pressure: proximal airway pressure (continuously monitored). Flow: inspiratory and expiratory flow sensors. Volume: calculated from flow integration. FiO2: oxygen analyzer in inspiratory limb. Temperature: humidifier output temperature. CO2: end-tidal CO2 (capnography).

User Interface

Touchscreen: set parameters, view waveforms. Alarms: high/low pressure, volume, rate, FiO2, apnea. Data display: real-time waveforms (pressure, flow, volume vs. time). Trends: hours to days of parameter history. Communication: ventilator data feeds to electronic medical record.

Ventilation Modes

Controlled Mandatory Ventilation (CMV)

Machine-triggered: ventilator delivers breaths at set rate. Patient: no spontaneous breathing (paralyzed or deeply sedated). Control: volume-controlled (VC-CMV) or pressure-controlled (PC-CMV). Use: initial resuscitation, paralyzed patients. Risk: patient-ventilator dyssynchrony if patient awakens.

Assist-Control (A/C)

Dual trigger: machine delivers mandatory breaths AND assists patient-triggered breaths. Patient effort: triggers additional breaths (sensitivity adjustable). Each breath: full ventilator support (same volume or pressure). Most common: initial ICU ventilation mode. Advantage: guarantees minimum minute ventilation.

Synchronized Intermittent Mandatory Ventilation (SIMV)

Mandatory breaths: synchronized with patient effort. Between mandatory: patient breathes spontaneously (with or without pressure support). Weaning: gradually reduce mandatory rate. Disadvantage: increased work of breathing during spontaneous breaths. Use: decreasing popularity (PS preferred for weaning).

Pressure Support Ventilation (PSV)

Patient-triggered: every breath initiated by patient. Support: set pressure boost during inspiration. Cycling: flow-based (terminates when flow drops to 25% of peak). Advantage: comfortable, reduces work of breathing. Application: weaning, spontaneous breathing trials. Requirement: patient must have respiratory drive.

Mode Comparison

Pressure vs. Volume Control

Volume-Controlled Ventilation (VCV)

Set parameters: tidal volume, respiratory rate, flow rate, flow pattern. Guaranteed: tidal volume delivered regardless of lung compliance. Variable: airway pressure changes with compliance/resistance. Risk: high pressures if compliance worsens (barotrauma). Monitoring: watch peak and plateau pressures closely.

Pressure-Controlled Ventilation (PCV)

Set parameters: inspiratory pressure, respiratory rate, I:E ratio. Guaranteed: pressure limited (lung-protective). Variable: tidal volume changes with compliance. Risk: hypoventilation if compliance worsens (tidal volume drops). Advantage: decelerating flow pattern (better gas distribution).

Pressure-Regulated Volume Control (PRVC)

Hybrid: targets volume but limits pressure. Algorithm: ventilator adjusts pressure breath-by-breath to achieve target volume. Advantage: volume guarantee with pressure protection. Disadvantage: may mask compliance changes. Use: growing popularity as "best of both worlds."

Key Pressures

Peak pressure (Ppeak): highest pressure during inspiration (includes resistive + elastic components). Plateau pressure (Pplat): pressure during end-inspiratory hold (reflects alveolar pressure). Driving pressure: Pplat - PEEP (predicts lung injury). Target: Pplat < 30 cmH2O, driving pressure < 15 cmH2O.

PEEP and Lung Recruitment

Positive End-Expiratory Pressure

Definition: pressure maintained at end of expiration (prevents alveolar collapse). Typical: 5-20 cmH2O (higher in ARDS). Mechanism: keeps alveoli open (recruitment), improves oxygenation. Trade-off: higher PEEP → better oxygenation but → may reduce cardiac output (increased intrathoracic pressure).

Recruitment Maneuvers

Concept: sustained high pressure opens collapsed alveoli. Methods: sustained inflation (40 cmH2O × 40 seconds), incremental PEEP titration. Risk: barotrauma, hemodynamic compromise. Evidence: mixed (may help in early ARDS, avoid in late). Monitoring: watch for pneumothorax, hypotension.

Optimal PEEP

Goal: best oxygenation with least hemodynamic compromise. Methods: PEEP-FiO2 tables (ARDSNet), decremental PEEP trial, pressure-volume curve analysis. Individualized: compliance-guided (best compliance at optimal PEEP). Controversy: no single method proven superior. Clinical: balance oxygenation improvement vs. cardiac output.

Auto-PEEP (Intrinsic PEEP)

Cause: incomplete expiration (air trapping). Risk factors: high respiratory rate, long I:E ratio, obstructive disease. Detection: end-expiratory hold maneuver (reveals trapped pressure). Consequence: increased work of breathing, hemodynamic compromise. Treatment: reduce rate, increase expiratory time, bronchodilators.

Monitoring and Waveforms

Pressure-Time Waveform

Shape: depends on mode. VCV: rising pressure during inspiration, plateau during pause. PCV: square wave (constant pressure during inspiration). Information: peak pressure, plateau pressure, PEEP, auto-PEEP.

Flow-Time Waveform

Inspiration: positive flow (into patient). Expiration: negative flow (out of patient). VCV: constant or decelerating flow pattern. PCV: decelerating flow (highest at start). Air trapping: expiratory flow doesn't reach zero before next breath.

Volume-Time Waveform

Inspiration: volume increases linearly or exponentially. Expiration: volume decreases (returns to baseline). Leak: inspired volume > expired volume (cuff leak, circuit leak). Monitoring: detect leaks, verify tidal volume delivery.

Pressure-Volume Loop

Shape: counterclockwise loop (inspiration right, expiration left). Lower inflection point: indicates opening pressure (recruitment). Upper inflection point: indicates overdistension pressure. Optimal PEEP: above lower inflection, below upper. Compliance: slope of loop (steeper = more compliant).

Capnography

End-tidal CO2 (ETCO2): CO2 at end of expiration. Normal: 35-45 mmHg (correlates with PaCO2). Waveform: plateau shape (phase III). Abnormal: sloped plateau (V/Q mismatch), no waveform (esophageal intubation). Application: confirm intubation, monitor ventilation adequacy.

ARDS and Lung-Protective Ventilation

ARDS Definition

Acute onset: within 1 week of clinical insult. Bilateral opacities: chest imaging (not explained by effusion/atelectasis). Non-cardiogenic: not primarily heart failure. Severity: mild (PaO2/FiO2 200-300), moderate (100-200), severe (<100). Causes: pneumonia, sepsis, aspiration, trauma, pancreatitis.

Lung-Protective Strategy (ARDSNet)

Tidal volume: 6 mL/kg predicted body weight (low tidal volume). Plateau pressure: <30 cmH2O. PEEP: guided by PEEP-FiO2 table. FiO2: lowest to maintain SpO2 88-95%. Result: 22% relative mortality reduction (landmark ARMA trial, 2000). Standard of care: universally adopted.

Driving Pressure

Formula: Pplat - PEEP (reflects stress on open lung). Target: <15 cmH2O. Evidence: best predictor of mortality in ARDS (Amato 2015). Mechanism: represents strain on functional lung tissue. Optimization: adjust tidal volume and PEEP to minimize driving pressure.

Prone Positioning

Concept: turn patient face-down (16+ hours/day). Mechanism: improves V/Q matching, distributes ventilation more evenly. Evidence: PROSEVA trial showed 50% mortality reduction in severe ARDS. Indication: PaO2/FiO2 <150 despite optimal ventilation. Logistics: requires trained team, careful monitoring.

Neuromuscular Blockade

Paralysis: cisatracurium for 48 hours in early severe ARDS. Mechanism: prevents dyssynchrony, reduces oxygen consumption. Evidence: ACURASYS trial showed mortality benefit. Risk: ICU-acquired weakness with prolonged use. Current: early, short-course preferred.

Weaning from Ventilation

Readiness Assessment

Criteria: underlying cause improving, hemodynamically stable, adequate oxygenation (FiO2 ≤ 0.4, PEEP ≤ 8), alert and cooperative, cough reflex present. Assessment: daily screening for weaning readiness.

Spontaneous Breathing Trial (SBT)

Method: T-piece (no support) or low PS (5-8 cmH2O) for 30-120 minutes. Success: tolerated without distress (RR < 35, SpO2 > 90%, stable HR/BP). Failure: tachypnea, desaturation, diaphoresis, agitation. Action: pass → extubate; fail → rest, retry next day.

Rapid Shallow Breathing Index (RSBI)

Formula: respiratory rate / tidal volume (in liters). Threshold: < 105 breaths/min/L predicts successful weaning. Sensitivity: ~97% (good at identifying who will succeed). Specificity: ~60% (many false positives). Use: screening tool before SBT.

Difficult Weaning

Definition: fails ≥ 3 SBTs or requires > 7 days after first SBT. Causes: respiratory muscle weakness, cardiac dysfunction, psychological dependence. Strategy: gradual reduction, rehabilitation, address underlying cause. Tracheostomy: considered if prolonged ventilation expected (>14 days). Outcome: most eventually wean with patience and appropriate management.

Complications

Ventilator-Induced Lung Injury (VILI)

Barotrauma: excessive pressure → pneumothorax, pneumomediastinum. Volutrauma: overdistension → alveolar damage. Atelectrauma: repeated opening/closing of alveoli → inflammation. Biotrauma: mechanical stress releases inflammatory mediators → systemic inflammation. Prevention: lung-protective ventilation (low tidal volume, appropriate PEEP).

Ventilator-Associated Pneumonia (VAP)

Incidence: 5-15% of ventilated patients. Onset: >48 hours after intubation. Organisms: Gram-negative (Pseudomonas, Klebsiella), Staphylococcus aureus. Prevention bundle: head elevation (30-45°), oral care, subglottic suctioning, daily sedation vacation. Mortality: 13-25% attributable mortality.

Oxygen Toxicity

Mechanism: high FiO2 generates reactive oxygen species. Threshold: FiO2 > 0.6 for >24 hours (risk increases). Damage: alveolar epithelial injury, surfactant dysfunction. Prevention: target lowest FiO2 to maintain SpO2 88-95%. Balance: avoid both hypoxemia and hyperoxia.

Diaphragm Dysfunction

Mechanism: disuse atrophy from controlled ventilation. Timeline: significant atrophy within 18-48 hours. Consequence: difficulty weaning, prolonged ventilation. Prevention: maintain spontaneous breathing when possible. Treatment: gradual increase in patient effort during weaning.

Emerging Technologies

Closed-Loop Ventilation

Concept: ventilator automatically adjusts settings based on patient response. Examples: INTELLiVENT-ASV (Hamilton), SmartCare (Drager). Inputs: SpO2, ETCO2, respiratory mechanics. Outputs: adjust FiO2, PEEP, pressure support, rate. Evidence: non-inferior to physician-controlled, may reduce workload.

Electrical Impedance Tomography (EIT)

Concept: real-time imaging of lung ventilation distribution. Electrodes: belt around chest (non-invasive). Data: regional ventilation map (identifies overdistension, collapse). Application: personalize PEEP, detect pneumothorax, guide recruitment. Status: commercial devices available, growing clinical adoption.

Esophageal Pressure Monitoring

Balloon catheter: measures pleural pressure (estimates transpulmonary pressure). Application: optimize PEEP in obese patients, ARDS. Transpulmonary pressure: airway pressure minus pleural pressure (true distending pressure). Evidence: EPVent-2 trial (improved oxygenation, trending toward mortality benefit).

High-Flow Nasal Cannula (HFNC)

Flow: 30-60 L/min heated humidified oxygen. Mechanism: washes out dead space, provides modest PEEP (~3-5 cmH2O). Application: mild-moderate hypoxemia (avoiding intubation). Comfort: better tolerated than NIV mask. Evidence: FLORALI trial (reduced intubation rate vs. standard oxygen).

References

• ARDS Network. "Ventilation with Lower Tidal Volumes for Acute Lung Injury and ARDS." New England Journal of Medicine, vol. 342, no. 18, 2000, pp. 1301-1308.
• Guerin, C., Reignier, J., Richard, J. C., et al. "Prone Positioning in Severe Acute Respiratory Distress Syndrome." New England Journal of Medicine, vol. 368, no. 23, 2013, pp. 2159-2168.
• Tobin, M. J. "Principles and Practice of Mechanical Ventilation." McGraw-Hill, 3rd ed., 2013.
• Boles, J. M., Bion, J., Connors, A., et al. "Weaning from Mechanical Ventilation." European Respiratory Journal, vol. 29, no. 5, 2007, pp. 1033-1056.
• Slutsky, A. S., and Ranieri, V. M. "Ventilator-Induced Lung Injury." New England Journal of Medicine, vol. 369, no. 22, 2013, pp. 2126-2136.